Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NEOGEN CORP Director's Dealing 2021

Oct 15, 2021

32081_dirs_2021-10-14_1cca41d1-950b-4d6e-8d68-3c68a83b4596.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGEN CORP (NEOG)
CIK: 0000711377
Period of Report: 2021-10-12

Reporting Person: ADENT JOHN EDWARD (Director, President & CEO)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-10-12 Common Stock (Right to Buy) $9.71 M 150352 Acquired 2026-11-12 Common Stock (150352) Direct
2021-10-12 Restricted Stock Units $40.85 M 15317 Acquired 2026-10-12 Common Stock (15317) Direct

Footnotes

F1: The options have five year lives, and vest in equal annual installments on each of the first five anniversary dates of the grant

F2: RSUs have five year lives, vesting in equal annual installments on each of the first five anniversary dates of the grant